On April 26, 2022, Adagio Therapeutics Inc announced that it has filed a preliminary proxy material with SEC and urged the shareholders to vote for its board nominees at the annual meeting of shareholders scheduled to be held on May 26, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.51 USD | +6.36% | +13.06% | -36.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.29% | 281M | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- IVVD Stock
- News Invivyd, Inc.
- Adagio Therapeutics Inc Solicits Proxies from Shareholders